Market closed
LakeShore Biopharma Co. Ltd/$LSB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Ticker
$LSB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
758
Website
LSB Metrics
BasicAdvanced
$44M
-
-$5.58
0.62
-
Price and volume
Market cap
$44M
Beta
0.62
52-week high
$2.80
52-week low
$1.81
Financial strength
Current ratio
1.126
Quick ratio
0.864
Long term debt to equity
17.219
Total debt to equity
72.532
Interest coverage (TTM)
-8.08%
Management effectiveness
Return on assets (TTM)
-13.85%
Return on equity (TTM)
-65.99%
Valuation
Price to revenue (TTM)
0.31
Price to book
0.07
Price to tangible book (TTM)
0.08
Price to free cash flow (TTM)
-0.524
Growth
Revenue change (TTM)
-16.56%
Earnings per share change (TTM)
72.17%
3-year revenue growth (CAGR)
30.67%
3-year earnings per share growth (CAGR)
9.33%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for LakeShore Biopharma Co. Ltd stock?
LakeShore Biopharma Co. Ltd (LSB) has a market cap of $44M as of April 04, 2025.
What is the P/E ratio for LakeShore Biopharma Co. Ltd stock?
The price to earnings (P/E) ratio for LakeShore Biopharma Co. Ltd (LSB) stock is 0 as of April 04, 2025.
Does LakeShore Biopharma Co. Ltd stock pay dividends?
No, LakeShore Biopharma Co. Ltd (LSB) stock does not pay dividends to its shareholders as of April 04, 2025.
When is the next LakeShore Biopharma Co. Ltd dividend payment date?
LakeShore Biopharma Co. Ltd (LSB) stock does not pay dividends to its shareholders.
What is the beta indicator for LakeShore Biopharma Co. Ltd?
LakeShore Biopharma Co. Ltd (LSB) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.